Open Access. Powered by Scholars. Published by Universities.®
Bacterial Infections and Mycoses Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antibiotic resistance (1)
- Antimicrobial resistance (1)
- Bacterial topoisomerase I (1)
- COVID-19 (1)
- DNA (1)
-
- Drug discovery (1)
- Drug repurposing (1)
- Ethacridine (1)
- HTOP1 (1)
- HTOP3B (1)
- In-silico screening (1)
- Inflammation (1)
- Inhibitors (1)
- Mutants (1)
- Mycobacteria (1)
- Resistance (1)
- SAR (1)
- SARS-CoV-2 (1)
- Sepsis (1)
- Septic shock (1)
- TB therapy (1)
- Topoisomerase (1)
- Topoisomerases (1)
- Toxin (1)
- Tuberculosis (1)
- WGS (1)
Articles 1 - 2 of 2
Full-Text Articles in Bacterial Infections and Mycoses
Type I Topoisomerases As Potential Targets For Therapeutics, Ahmed Seddek
Type I Topoisomerases As Potential Targets For Therapeutics, Ahmed Seddek
FIU Electronic Theses and Dissertations
DNA topoisomerases are universal enzymes that control the topological features of DNA in all forms of life. This study aims to find potential inhibitors of some of the DNA topoisomerases in bacteria and humans that can be developed into potential therapeutics.
The first aim of this study is to find potential inhibitors of bacterial topoisomerase I that can be developed into antibiotics. There is an urgent need to develop novel antibiotics to overcome the world-wide health crisis of antimicrobial resistance. Virtual screening and biochemical assays were combined to screen thousands of compounds for potential inhibitors of bacterial topoisomerase I. NSC76027 …
Mycobacterium Tuberculosis Inhibitors: Action And Resistance, Pamela K. Garcia-Moreno
Mycobacterium Tuberculosis Inhibitors: Action And Resistance, Pamela K. Garcia-Moreno
FIU Electronic Theses and Dissertations
Tuberculosis, an infectious disease caused by Mycobacterium tuberculosis, has been a global health problem for years. The emergence of drug resistance in this organism generates the necessity of exploring novel targets and developing new drugs. Topoisomerases are enzymes found in all kingdoms of life responsible for overcoming the topological barriers encountered during essential cellular processes. The genomes of mycobacteria encode only one type IA topoisomerase (MtopI), which has been validated as a novel TB drug target. The goal of this study is to obtain new information on the mechanism and resistance of endogenous and synthetic inhibitors of MtopI.
Rv1495 is …